Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry-Kravis

Showing results (151-160 of 265) with videos related to

Pageof 27
Sort By:
Journal of Neuropathology and Experimental Neurology|July 4, 2024
Accumulation of TMEM106B C-terminal fragments in Niemann-Pick type C diseaseRuth D Azaria, Sean P Ferris, Randy S Tashjian, et al.
Plos One|July 27, 2019
Language processing skills linked to FMR1 variation: A study of gaze-language coordination during rapid automatized naming among women with the FMR1 premutationKritika Nayar, Walker McKinney, Abigail L Hogan, et al.
Journal of Proteome Research|August 14, 2020
Optimization of Protocols for Detection of De Novo Protein Synthesis in Whole Blood Samples via Azide-Alkyne CycloadditionHeather L Bowling, Amanda Kasper, Chhaya Patole, et al.
Pediatrics|August 18, 2017
FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X SyndromeStephanie L Sherman, Sharon A Kidd, Catharine Riley, et al.
Neurobiology of Disease|May 19, 2026
Cerebellar GABA and executive function among adult female carriers of the fragile X messenger ribonucleoprotein 1 premutation: a pilot study to examine neural underpinnings of the clinical phenotypeRoslyn Harold, Roma Kamat, Wei Siong Neo, et al.
Journal of Neurodevelopmental Disorders|June 16, 2017
Arbaclofen in fragile X syndrome: results of phase 3 trialsElizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, et al.
Journal of Autism and Developmental Disorders|October 6, 2011
Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatmentStephanie M Sansone, Keith F Widaman, Scott S Hall, et al.
Journal of Neurodevelopmental Disorders|September 8, 2016
The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directionsDavid Hessl, Stephanie M Sansone, Elizabeth Berry-Kravis, et al.
Pediatric Neurology|July 15, 2020
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X SyndromeElizabeth Berry-Kravis, Joseph P Horrigan, Nicole Tartaglia, et al.
Science Advances|August 29, 2019
Data-driven phenotype discovery of <i>FMR1</i> premutation carriers in a population-based sampleArezoo Movaghar, David Page, Murray Brilliant, et al.
Pageof 27

Showing results (151-160 of 265) with videos related to

Sort By:
Pageof 27
Journal of Neuropathology and Experimental Neurology|July 4, 2024
Accumulation of TMEM106B C-terminal fragments in Niemann-Pick type C diseaseRuth D Azaria, Sean P Ferris, Randy S Tashjian, et al.
Plos One|July 27, 2019
Language processing skills linked to FMR1 variation: A study of gaze-language coordination during rapid automatized naming among women with the FMR1 premutationKritika Nayar, Walker McKinney, Abigail L Hogan, et al.
Journal of Proteome Research|August 14, 2020
Optimization of Protocols for Detection of De Novo Protein Synthesis in Whole Blood Samples via Azide-Alkyne CycloadditionHeather L Bowling, Amanda Kasper, Chhaya Patole, et al.
Pediatrics|August 18, 2017
FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X SyndromeStephanie L Sherman, Sharon A Kidd, Catharine Riley, et al.
Neurobiology of Disease|May 19, 2026
Cerebellar GABA and executive function among adult female carriers of the fragile X messenger ribonucleoprotein 1 premutation: a pilot study to examine neural underpinnings of the clinical phenotypeRoslyn Harold, Roma Kamat, Wei Siong Neo, et al.
Journal of Neurodevelopmental Disorders|June 16, 2017
Arbaclofen in fragile X syndrome: results of phase 3 trialsElizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, et al.
Journal of Autism and Developmental Disorders|October 6, 2011
Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatmentStephanie M Sansone, Keith F Widaman, Scott S Hall, et al.
Journal of Neurodevelopmental Disorders|September 8, 2016
The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directionsDavid Hessl, Stephanie M Sansone, Elizabeth Berry-Kravis, et al.
Pediatric Neurology|July 15, 2020
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X SyndromeElizabeth Berry-Kravis, Joseph P Horrigan, Nicole Tartaglia, et al.
Science Advances|August 29, 2019
Data-driven phenotype discovery of <i>FMR1</i> premutation carriers in a population-based sampleArezoo Movaghar, David Page, Murray Brilliant, et al.
Pageof 27